Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Oct 6, 2009

Premium

Arrayit last week launched a proteomics microarray platform for customers working in the areas of proteomics and in vitro molecular diagnostics.

Arrayit said the platform provides instrumentation, software, and consumables solution for peptide microarray analysis.


Expression Analysis launched a new grant program last week, under which four researchers will be given access to Expression Analysis' services. The firm said that two of the grants will focus on genome-wide association studies, and the other two will focus on follow-up studies to GWAS. Included in the grants is data analysis using Expression Analysis' digenysis analysis tool, which simultaneously analyzes allelic and copy number variation. Researchers may apply for the grants on Expression Analysis' website through Dec. 1.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.